Skip to main content

Life Sciences

Register for This Webinar to Learn More About Siebel CTMS IP2019

by on October 11th, 2019 | ~ minute read

Siebel CTMS

Has your organization been thinking about upgrading your Siebel Clinical Trial Management (CTMS) system to the latest version available, but aren’t exactly sure what the potential benefits an upgrade could bring? With the newest version of Siebel, Innovation Pack 2019 (IP2019), there are some significant updates that bring key features and benefits to end users. There are also platform-wide upgrades that make development easier and more efficient, not to mention infrastructure and administration improvements, which could make maintenance and support even more streamlined.

Below are some key benefits of IP2019 and how they impact specific types of users:

AI at Perficient
Revolutionize Your Business With Generative AI

From product design and software development to virtual agents, content creation, and reporting, GenAI is transforming business. Our AI experts help you unlock GenAI’s full potential and drive growth.

Let’s Get Started

Siebel CTMS

If you have Siebel CTMS, I’d like to invite you to a webinar to learn more about IP2019. If you are not familiar, but are in the process of evaluating CTMS solutions, join me to hear why the most prominent life sciences organizations have implemented Oracle’s CTMS.

Register for the webinar: Oracle Siebel CTMS IP2019 Highlights and Upgrade Considerations

Tags

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Param Singh

Param Singh has been working in the life sciences industry his entire career. As the director of clinical trial management solutions at Perficient, he developed the clinical trial management team to become one of the best in the industry. Param leads a highly skilled team of implementation specialists and continues to build lasting relationships with clients. He has a knack for resource and project management, which allows clients to achieve success. Param has been with Perficient, via the acquisition of BioPharm Systems, since 2008. Prior to joining the company, he guided the clinical trial management group at Accenture.

More from this Author

Categories
Follow Us